News for Providers
Top stories summarized by our editors
10/15/2018

A study in Diabetes Care showed a 24% increased risk for type 2 diabetes for every one standard deviation increase in fasting plasma glucose coefficient of variation. Researchers evaluated data from the Korean National Health Insurance System involving 131,744 people without diabetes at baseline and found that older males who completed little physical activity, had a higher incidence of dyslipidemia and hypertension, drank alcohol and smoked had greater variation of fasting plasma glucose levels.

Full Story:
Endocrinology Advisor
More Summaries:
diabetes, Diabetes Care, dyslipidemia
10/15/2018

Adults with type 1 diabetes who used inhaled insulin had less time spent in hypoglycemia and a lower glucose standard deviation at four weeks, compared with those on insulin aspart, according to a study in Diabetes Technology & Therapeutics. Researchers recruited 60 diabetes patients and found those in the inhaled insulin group also lost more weight.

10/15/2018

A study presented at the American Society for Bone and Mineral Research's annual meeting found that men with type 2 diabetes had higher advanced glycation end-product content in the cortical bone of the femoral neck, which is associated with reduced bone strength, compared with those without diabetes. Researchers analyzed 65 men with and without diabetes and found no association between AGE content and A1C levels, but increased AGE content correlated with lower initiation toughness.

10/15/2018

A device that uses Raman spectroscopy to measure blood glucose levels through the skin by producing a "molecular fingerprint" has been developed by researchers from MIT and the University of Missouri School of Medicine. They conducted a study with individuals without diabetes and found that the device and a finger prick test had similar efficacy in assessing blood glucose levels.

10/12/2018

Support funding for medical and social services for persons living with HIV/AIDS from the US federal government have exceeded more than $2 billion in fiscal year 2018. More than $820 million went to states for the AIDS Drug Assistance Program, which provide medications to patients who are low-income and are underinsured or uninsured.

10/12/2018

Goats are becoming a common sight in West Sacramento, Calif., as people look to the ruminants to reduce wildfire hazards on their properties. Goats eat dry grass and debris that can fuel wildfires.

10/12/2018

Researchers found that women who had the highest levels in the normal range of prolactin, a breastfeeding-related hormone, were at a 27% reduced risk for type 2 diabetes, compared with those who had the lowest but still normal levels of the hormone. The findings in Diabetologia were based on more than 8,600 healthy US women.

Full Story:
HealthDay News
10/12/2018

Patients with type 1 diabetes who took empagliflozin significantly improved their glycemic control and reduced their weight without an increased rate of symptomatic or severe hypoglycemia, compared with those on placebo, according to a study presented at the European Association for the Study of Diabetes meeting and published in Diabetes Care. Researchers used a cohort of 1,707 patients from the EASE trials and found those who took the 10-mg and 25-mg doses of empagliflozin were up to four times more likely to develop diabetic ketoacidosis and genital infections, compared with the placebo group.

More Summaries:
Diabetic ketoacidosis
10/12/2018

The merger of CVS Health and Aetna will accelerate the trend toward consumer-oriented health care and could force some providers to reconsider their business model, said PwC Health Service Leader Gurpreet Singh. More nontraditional retail and technology providers will enter the health care market, Singh said, and hospitals may have to focus on a particular strength, such as integrated care or customer service, to succeed.

Full Story:
HealthLeaders Media
More Summaries:
Gurpreet Singh, CVS Health, Aetna
10/12/2018

The FDA has approved Palynziq, or pegvaliase, as a treatment for adults with phenylketonuria. "Pegvaliase is very effective in metabolizing phenylalanine, making it possible for most patients who respond to the medication to consume a normal amount of food protein," study author Barbara Burton said.

Full Story:
Rare Disease Report
More Summaries:
FDA, Pegvaliase, Palynziq